Was the efficacy number not 71%? Or slightly better?
There have been numerous drugs approved by FDA where efficacy factor was <5%. ActiPatch truly is a magical device.
Just have to clean up the share structure and governance structure.
FDA General Clearance including the back and not one shift in share price .0009. With magical aspects of cleared ActiPatch can only be the toxicity of the Whelan name from previous management and share structure - nothing else makes any sense.
213951 February 9, 2020
2 out of 3 deals signed this coming week? After 12 years of obfuscation, bungling and unfulfilled expectations under the previous CEO? Keith Nalepka, and Drs Koneru and Staelin are miracle workers!
The problem may not be one of shareholder expectations or investor confidence. BIEL now has the necessary FDA general clearance to go to the moon. I accept that wholeheartedly.
Could it be that the commercial market, into which BIEL wants to brand and market its' devices is not buying the new management? Is it possible that the commercial players, to whom BIEL said "No", are reluctant to joining forces with BIEL to assuage the many forms of pain experienced by many tens of millions of pain sufferers, just in the U.S.? I'm trying to use the same logic that led me to wonder if the CE Mark had expired, the one that is required for the EU and Australia, which remain closed to BIEL until its' new CE Mark is granted.
BIEL can now confidently enter the real world of various pain areas now - Acute, Chronic, Breakthrough, Bone, Soft tissue, Nerve, Referred, and perhaps less so, Phantom pain. But what if buyers at CVS, who got a "No" from the former CEO, Dr. Scholl's, who got a "No" from the former CEO and KT Tape, who got a "No" from the former CEO, all exhibit 'once burnt, twice shy' symptoms? What if they can't get past the understandable human responses of not wanting to be embarrassed twice and move forward with Keith Nalepka to generating amazing sales and profits from ActiPatch?
Then the solution is very, very simple! Whomever is first to the table with BIEL, the new BIEL, will be just that - first in the ever-present race to generating amazing sales and profitability over their competition. That is the task of Keith Nalepka, VP Sales; to convince them they will be okay in trusting him and the BIEL team to deliver on promises made! Why? Because the former CEO, took a form of early retirement and that was then and this is now and ActiPatch is still the amazing disruptive technology of miniaturized pain remediation it was when they first believed in it. Before they got the outrageous and irrational "No". As I have said before, dementia is among the very worst issues families can face. and now we see, businesses too. Enough said. I'm still sad at what happened, but it happened. I'm human.
Keith Nalepka may have his work cut out for him, as VP Sales, but he is a pro and he will convince the marketplace to take a chance on the new BIEl, of that we can be confident. Now what else can management do to assist in the advancement of BIEL in the marketplace? How about lifting it out of the toilet, the former guy buried it in? Yup, the 7-step management remediation plan. May as well fix it all and get this puppy operating properly. Along with the CE Mark which will open up the EU, including the UK and Australia.
The 7-Step Management Remediation Plan
Post 208513, edited for size
“Only time with tell if Patricia and Kelly Whelan will do the right things, or not. It is to their direct financial benefit to just bite the imaginary bullet and protect themselves by incorporating vision:
1. SHARE STRUCTURE - Immediately revise the outrageous shareholdings of the Whelan/IBEX/St. Johns on conversion of all Promissory Notes of around 62 billion shares. The Whelans would own around 35 billion of that 62 billion or 60% +-. Reducing their shares by 28 billion, to 7 billion, new total becomes around 34 billion, they would then own 25% +-. Some say it should be reduced to 3.5 billion, whatever it takes to repair the previous damage. Would you rather own 60%, 35 billion shares, of a crippled company worth nothing and going nowhere fast, or 25%, 7 billion shares of a company under restructuring, that could be worth untold hundreds of millions of dollars?;
SYNOPSIS OF THE 7-STEP MANAGEMENT REMEDIATION PLAN DECEMBER 2019
1. SHARE STRUCTURE
2. TRANSPARENCY
3. FAIR OFFERS TO SHAREHOLDERS
4. TOXICITY
5. BOARD of DIRECTORS
6. COMMUNICATION NALEPKA KONERU
7. NEGOTIATE & SIGN DEALS AND DELIVER ON ALL PROMISES!
It's called owning a smaller piece of a bigger pie! Only fools don't change their minds. tic toc . . . . .
